Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients
NCT02491593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242
Last updated 2018-11-06
Summary
The aim of this study is to compare the outcome of three (3) quantitative immunochemical faecal occult blood test in symptomatic patients.
Conditions
- Colorectal Neoplasms
Interventions
- DEVICE
-
fecal occult blood test
Sponsors & Collaborators
-
Uppsala University
lead OTHER
Principal Investigators
-
Louise Olsson, MD, PhD · Centre for Clinical research, Eskilstuna, Uppsala universitet
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2017-03-01
- Completion
- 2017-03-01
Countries
- Sweden
Study Locations
More Related Trials
-
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
NCT04490551 ·Status: COMPLETED ·Phase: NA
-
Study of In-home Tests for Colorectal Cancer
NCT01998009 ·Status: COMPLETED ·Phase: NA
-
Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and Adenoma
NCT00197405 ·Status: UNKNOWN
-
A Comparison of Different Fecal Occult Blood Test for Colorectal Cancer Screening
NCT04454099 ·Status: COMPLETED
-
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
NCT05232721 ·Status: UNKNOWN
-
Single Center Randomized Pilot Study Of Colorectal Cancer Screening Outreach
NCT02594150 ·Status: COMPLETED ·Phase: NA
-
Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer
NCT03367611 ·Status: COMPLETED ·Phase: NA
-
Point of Care Faecal Immunochemical Testing for Colorectal Cancer
NCT04402424 ·Status: COMPLETED
-
Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening
NCT05200611 ·Status: UNKNOWN
-
Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer
NCT05115786 ·Status: UNKNOWN
-
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
NCT03251612 ·Status: COMPLETED ·Phase: PHASE2
-
Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
NCT00906997 ·Status: COMPLETED ·Phase: NA
-
Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses
NCT01194687 ·Status: COMPLETED
-
Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
NCT01741363 ·Status: COMPLETED ·Phase: NA
-
Reducing Colonoscopies in Patients Without Significant Bowel Disease
NCT04516785 ·Status: COMPLETED
-
Retrospective Study on Epidemiology of Colorectal Lesions
NCT03035136 ·Status: COMPLETED
-
A Trial of the Implementation of iFOBT in General Practice
NCT02308384 ·Status: COMPLETED ·Phase: NA
-
Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy
NCT00812942 ·Status: COMPLETED ·Phase: NA
-
Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery
NCT03070613 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
NCT00102011 ·Status: COMPLETED ·Phase: PHASE3
-
Faecal Immunochemical Tests (FIT) for Surveillance After Colorectal Cancer (CRC) Study
NCT06689293 ·Status: RECRUITING
-
Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland
NCT02560194 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test
NCT05172713 ·Status: UNKNOWN
-
A Predictive Model Based on Quantitative Fecal Immunochemical Test Can Stratify the Risk of CRC in an Organized Screening Program
NCT06607614 ·Status: NOT_YET_RECRUITING
-
Increasing Uptake of Bowel Screening
NCT05408169 ·Status: COMPLETED ·Phase: NA